Please assess the completion status of the following clinical trial:

Trial Title: Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects with \>= 18 years of age~* Intact skin in the area of topical treatment~* Patients suffering from moderate to severe ( 5 or more points on an 11 point Numerical Rating Scale where 10 is the worst possible pain, and 0 indicates no pain) chronic daily postoperative neuropathic pain for the past 6 to 24 months.~* Patients should have symptoms for example allodynia (a pain due to a stimulus which does not normally provoke pain); and or dysesthesia (unpleasant, abnormal sense of touch).~Exclusion Criteria:~* Contraindications to lidocaine 5% medicated plaster, or paracetamol~* Evidence or history of alcohol, medication or drug abuse and/or dependency in the past 3 years.~* Evidence or history (during the past 3 years) of epilepsy, neurotic personality, psychiatric illness, or suicide risk.~* Pregnant or breastfeeding women~* Women of childbearing potential who are sexually active without satisfactory contraception for at least 28 days prior to enrollment, during the trial, and until 28 days after the follow-up visit.~* Severe renal, hepatic or heart disorder.~* Surgery in the past 3 months before screening.~* Anticipated need for surgery during the trial, requiring at least regional or general anesthesia.~* Pending litigation due to chronic pain or disability.~* Participation in another trial of investigational medicinal products or devices parallel to or less than 1 month before entry into the trial, or previous participation in this trial.~* Presence of other severe pain that could confound the assessment or self- evaluation of the localized postoperative neuropathic pain.~* For patients with chronic postoperative neuropathic pain related to a surgery due to tumors: suspected residual tumor or metastases, chemotherapy or radiotherapy for treatment of tumor(s).~* Total anesthesia in the area of localized chronic pain

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo Plaster (Type: PLACEBO_COMPARATOR): Active Comparator
- Lidocaine Plaster (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).